Umesh Prasad

Umesh Prasad is a researcher-communicator who excels at synthesizing peer-reviewed primary studies into concise, insightful, and well-sourced public articles. A specialist in knowledge translation, he is driven by a mission to make science inclusive for non-English speaking audiences. Toward this goal, he founded “Scientific European,” this innovative, multilingual, open-access digital platform. By addressing a critical gap in global science dissemination, Prasad acts as a key knowledge curator whose work represents a sophisticated new era of scholarly journalism, bringing the latest research to the doorstep of common people in their native languages.

Gravitational-wave Background (GWB): A Breakthrough in Direct Detection

Gravitational wave was directly detected for the first time in 2015 after a century of its prediction by Einstein’s General Theory of Relativity in 1916....

The Fireworks Galaxy, NGC 6946: What Make this Galaxy so Special?

NASA recently released the spectacular bright image of the firework galaxy NGC 6946 taken earlier by Hubble space telescope (1)   A galaxy is a system...

Space Biomining: Inching Towards Human Settlements Beyond Earth

The findings of the BioRock experiment indicate that bacterial supported mining can be carried out in the space. Following the success of BioRock study, the  BioAsteroid experiment is currently underway...

Human Proteome Project (HPP): Blueprint Covering 90.4% of the Human Proteome Released

Human Proteome Project (HPP) was launched in 2010 after successful completion of Human Genome Project (HGP) to identify, characterise and map human proteome (the...

COVID-19 mRNA Vaccine: A Milestone in Science and a Game Changer in Medicine

Viral proteins are administered as antigen in the form of a vaccine and the immune system of the body forms antibodies against the given...

Understanding Life-threatening COVID-19 Pneumonia

What causes severe COVID-19 symptoms? Evidences suggest inborn errors of type I Interferon immunity and autoantibodies against type I Interferon are causal for critical...

COVID-19: ‘Neutralising Antibody’ Trials Begins in the UK

University College London Hospitals (UCLH) has announced neutralising antibody trial against COVID-19. The announcement on 25 December 2020 says ‘’UCLH doses first patient in...

New Strains of SARS-CoV-2 (the virus responsible for COVID-19): Could ‘Neutralising Antibodies’ Approach be Answer to Rapid Mutation?

Several new strains of the virus have emerged since the pandemic began. New variants were reported as early as February 2020. The current variant...

Stay in touch:

87,790FansLike
45,138FollowersFollow
1,772FollowersFollow

Newsletter

Don't miss

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...